Searched for
POLYSACCHARIDE VACCINE
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 26%Just look at developments in the past 48 hours. The war between Iran and Israel resumed, but within hours Tehran said it had halted all off...- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 22%As the market grappled with confusion over the Strait of Hormuz, there was more trouble for the bulls. After a few days of respite, another...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%It is tough to think positively about the markets when all the news is about blockades, wars, and everything that can disturb the global ec...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%The official kickoff of the Q4 earnings season happens when a large IT company announces its results, although the quarter’s business updat...
- Think bullish, but learn to live with & ignore volatility: 5 stocks from different sectors with an upside potential of up to 42%The probability of a correction if there is no positive development on the India-US trade deal is quite high. The fact, however, remains th...
- We can be VAXit Bharat: Public sector alone can’t make India biotech-ready; firms, startups must jump inWhile India grapples with rising Covid cases and prepares for potential biological threats, the government's neglect of its scientists' suc...
- NPPA ropes in patent office to decide on pleas for price cap exemptionIndia's drug pricing regulator, NPPA, is increasing scrutiny of pharmaceutical companies seeking price exemptions. The NPPA is collaboratin...
- Tactical buys in time of correction? 4 MNC pharma stocks with upside potential of up to 28%In the last two decades MNC pharma companies, whose parent companies were setting up 100 percent owned subsidiaries in India and started ro...
- Will they make a comeback? 4 MNC pharma stocks with upside potential of up to 28%After the IT bull of 2000, as a new set of Indian companies took the centerstage, a number of MNCs stocks lost their shine at least on the ...
- Will MNC pharma stocks get back their mojo for good or is it just a blip?Most of the MNC pharma companies have formed their subsidiary and a large majority of new drugs launched in India were via this route. This...
- View: A safe sub-unit protein vaccine will further enhance booster protection against Covid variantsEven when Omicron variants like BF.7 are exhibiting increased capacity for evading immunity, antibody surge from boosters may prevent sever...
- SII to start supplying 1st made-in-India pneumococcal conjugate vaccine to Centre from WednesdayThe SII has to supply 2.4 crore doses of the vaccine to the Health Ministry by December 2021. It will be sent to 37 consignees all over Ind...
- Serum Institute develops first indigenous vaccine against pneumonia; to be launched next weekIndia's drug regulator in July had granted market approval for the Pneumococcal Polysaccharide Conjugate vaccine, after reviewing the phase...
- India's 1st fully indigenously developed vaccine against pneumonia gets DCGI nodThe ministry said the vaccine will be used for active immunisatiuon against invasive disease and pneumonia caused by 'Streptococcus pneumon...
- Marine red algae may hold key to preventing spread of COVID-19: Reliance researchersMarine red algae may hold key to prevent spread of coronavirus as biocompatible compounds extracted from them can be used as a coating mate...
- Lupin to market MSD's pneumonia prevention vaccine in IndiaAs part of the agreement promote and distribute MSD's 23-valent Pneumococcal Polysaccharide Vaccine under a different brand name in the cou...
- New meningitis vaccine for infants shows promiseA new vaccine, Menveo, has shown promise in clinical trials, which might help protect infants against four types of meningitis.
Load More
